The Impact of Abdominal Wall Closure Technique on Incidence of Incisional Hernia in Kidney Transplantation

NCT ID: NCT03959904

Last Updated: 2025-05-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-03-10

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

STUDY SUMMARY Incisional hernias, or swellings of the abdominal scar after surgery, remain problematic especially after transplant surgery. This is because they can cause complications, including trapping of bowel or the transplant. This can cause life threatening emergencies but is at the very least unsightly and uncomfortable for the patient. Transplant patients are especially likely to develop hernias because of the diseases causing the renal failure and the drugs that they take to dampen the immune system. There is evidence from other surgery that the stitching methods that are used to close the wounds might decrease the risk of surgical hernias. This is achieved by placing smaller and more numerous sutures (stitches) in the wound to increase the strength of the repair. However, this has never been tested formally in transplant where it may provide significant benefit. We intend to do some initial investigation of whether using the smaller stitches may provide benefit over more traditional methods that are currently being used. We will look at early complications after surgery but also the rate of hernia formation later. We hope to improve outcomes and reduce complications for our transplant patients by doing this. In addition we will collect blood and tissue samples from both live kidney donors and the recipients to microscopically analyse their collagen to identify potential factors which may indicate risk of hernia formation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study Design This study has two phases. In phase 1 we will perform a retrospective review of hernia incidence in our centre over the last decade. We will seek to identify risk factors in our transplant cohort. In phase 2 we will perform a prospective randomised blinded feasibility trial in which the conventional large bites technique will be compared with the small bites technique.

STUDY SETTING The study will be carried out on one site at Manchester Royal Infirmary, part of Manchester University National Health Service (NHS) Foundation Trust. This is a regional Renal and Pancreas Transplant centre performing approximately 60 pancreas transplants per annum and 350 kidney transplants. All members of the team have academic track records and participate in several on-going research projects. Current research projects are investigating cardiovascular disease, kidney perfusion, Magnetic Resonance (MR) imaging to name a few.

RESEARCH QUESTIONS, AIMS, AND OBJECTIVES

Phase 1 To retrospectively evaluate the incidence of incisional hernias in our transplant population and associated risk factors.

Phase 2

1. To perform prospective randomized double blinded feasibility trial to investigate the use of "small bites" (SB) vs "large bites (LB)" for closure of abdominal incisions following kidney transplantation.
2. To collect detailed medical histories from all patients included in the study to look for potential medical risk factors which may predispose to hernia formation.
3. To collect tissue and blood samples to investigate potential biological and histological markers of hernia formation, from both patients with end stage renal failure receiving a living-donor kidney transplant, and samples from the donor nephrectomy patients for histological comparison.
4. To assess quality of life and pain scores in the early and delayed post-operative phase (week 1, 6 months and 1 year)

Outcomes Phase 1 Incidence of Incisional Hernia within 1 and 3 years post-transplant clinically or radiologically detected.

Phase 2 Primary outcome Incidence of Incisional Hernia within one year post transplant, either clinically or radiologically detected. Any incisional hernia identified will be classified as per European Hernia Society Guidelines.

Secondary outcomes Incidence of post-operative complications at 6 months post op (burst abdomen, chest infection, surgical site infection returns to theatre,etc), pain score, costs, length of hospital stay, quality of life at week 1, 6 and 12 months post-transplant, collagen and serum biomarkers which may predispose to hernia formation

Sampling and recruitment Sample identification Phase 1 Data will be collected from the medical records of our Transplant population and entered into an excel spreadsheet no personal identifiers will be recorded.

Phase 2 The Chief Investigator (CI) and Principle Investigator (PI) will identify patients on the transplant waiting list and send copies of the information sheet.

Following ethical approval, patients undergoing first or second renal transplantation will be asked for informed consent to participate in the study to receive either small or large bites.

The CI and PI are part of the direct care team. The CI will have custody of the clinical information.

Clinical details will be recorded on hospital pass worded computers. Blood samples will be anonymised at the time of collection. Patients will be given a study code and blood samples will be labelled with this code to ensure anonymity.

The custodian of the data and samples will be the CI.Mr David van Dellen.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surgery--Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

2 groups randomised to different suturing techniques following surgery
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Small Stitch

Small stitch for wound closure

Group Type ACTIVE_COMPARATOR

Small stitch

Intervention Type PROCEDURE

Wound closure will be using small stiches or larger spaced stitches

Blood sample

Intervention Type OTHER

A blood sample to look for biological markers of Hernia formation will be taken

Tissue Sample

Intervention Type OTHER

A tissue sample will be taken to measure markers of wound healing.

Pain Score

Intervention Type OTHER

A pain score will be recorded following the surgical procedure.

Quality of Life Score

Intervention Type OTHER

A Quality of Life Score will be recorded at 1 month 6 months and 12 months post surgery

Large Stitch

Large Stitch for wound closure

Group Type ACTIVE_COMPARATOR

Small stitch

Intervention Type PROCEDURE

Wound closure will be using small stiches or larger spaced stitches

Blood sample

Intervention Type OTHER

A blood sample to look for biological markers of Hernia formation will be taken

Tissue Sample

Intervention Type OTHER

A tissue sample will be taken to measure markers of wound healing.

Pain Score

Intervention Type OTHER

A pain score will be recorded following the surgical procedure.

Quality of Life Score

Intervention Type OTHER

A Quality of Life Score will be recorded at 1 month 6 months and 12 months post surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Small stitch

Wound closure will be using small stiches or larger spaced stitches

Intervention Type PROCEDURE

Blood sample

A blood sample to look for biological markers of Hernia formation will be taken

Intervention Type OTHER

Tissue Sample

A tissue sample will be taken to measure markers of wound healing.

Intervention Type OTHER

Pain Score

A pain score will be recorded following the surgical procedure.

Intervention Type OTHER

Quality of Life Score

A Quality of Life Score will be recorded at 1 month 6 months and 12 months post surgery

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Large Stitch

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* End-stage renal failure patients
* Aged 18-70yrs
* First transplants or second transplants
* Ability to adequately understand English and consent for study
* BMI\<35 kg/m2)

Exclusion Criteria

* Outside age range,
* Previous transplants which have left a scar in the ilia fossa
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Manchester University NHS Foundation Trust

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Manchester University NHS Foundation Trust

Manchester, , United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Alex Shaw

Role: CONTACT

+441617012066 ext. 12066

Angela Summers, PhD

Role: CONTACT

+441617012066 ext. 12066

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Angela Summers

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

B00469

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Trunk Strength Study
NCT01300936 COMPLETED